FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108304057> ?p ?o ?g. }

• W2108304057 endingPage "1055" @default.
• W2108304057 startingPage "1049" @default.
• W2108304057 abstract "OBJECTIVE: To review the availability, mechanisms, limitations, and clinical application of point-of-care (POC) devices used in the management of warfarin and parenteral direct thrombin inhibitors. DATA SOURCES: Scientific articles were identified through a MEDLINE search (1966–August 2004), manufacturer Web sites, additional references listed in articles and Web sites, and abstracts from scientific meetings. STUDY SELECTION AND DATA EXTRACTION: English-language literature from clinical trials was reviewed to evaluate the accuracy, reliability, and clinical application of POC monitoring devices. DATA SYNTHESIS: The prothrombin time expressed as the international normalized ratio (PT—INR) is a well-established test for monitoring warfarin anticoagulation. Multiple devices are available for POC testing. Because there is no universally accepted standard, the performance of each device is typically tested against a standard test performed in a reference laboratory. Performance of currently available devices, as measured by correlations to a standard reference laboratory PT—INR, may be considered very good and acceptable for use in patient care. Utilization of patient self-testing and patient self-monitoring of warfarin anticoagulation using POC devices is increasing. Parenteral direct thrombin inhibitors are typically monitored using a standard laboratory activated partial thromboplastin time. Some research has shown that POC monitoring of direct thrombin inhibitors using the ecarin clotting time is helpful for patients undergoing cardiopulmonary bypass surgery, although that test is not readily available. CONCLUSIONS: POC testing for anticoagulation therapy has been available for >20 years. Multiple POC devices are available to monitor warfarin. There is some variability in results between devices and between reagents used in the same device. Despite these limitations, POC monitoring of warfarin via the PT—INR is an integral part of clinical practice. Additional research evaluating POC monitoring of direct thrombin inhibitors is necessary." @default.
• W2108304057 created "2016-06-24" @default.
• W2108304057 creator A5025013886 @default.
• W2108304057 creator A5030740027 @default.
• W2108304057 creator A5076594754 @default.
• W2108304057 creator A5084577356 @default.
• W2108304057 date "2005-06-01" @default.
• W2108304057 modified "2023-10-11" @default.
• W2108304057 title "Anticoagulation Monitoring Part 1: Warfarin and Parenteral Direct Thrombin Inhibitors" @default.
• W2108304057 cites W126394780 @default.
• W2108304057 cites W1501820105 @default.
• W2108304057 cites W162726646 @default.
• W2108304057 cites W188744978 @default.
• W2108304057 cites W1964890506 @default.
• W2108304057 cites W1978193003 @default.
• W2108304057 cites W1980914043 @default.
• W2108304057 cites W1986945638 @default.
• W2108304057 cites W1998226978 @default.
• W2108304057 cites W2004068195 @default.
• W2108304057 cites W2004423916 @default.
• W2108304057 cites W2012923240 @default.
• W2108304057 cites W2019452952 @default.
• W2108304057 cites W2024332049 @default.
• W2108304057 cites W2029429532 @default.
• W2108304057 cites W2056771252 @default.
• W2108304057 cites W2064219399 @default.
• W2108304057 cites W2068970060 @default.
• W2108304057 cites W2091637137 @default.
• W2108304057 cites W2096593843 @default.
• W2108304057 cites W2096788325 @default.
• W2108304057 cites W2099591915 @default.
• W2108304057 cites W2101979147 @default.
• W2108304057 cites W2102296549 @default.
• W2108304057 cites W2124251575 @default.
• W2108304057 cites W2162244623 @default.
• W2108304057 cites W2165710426 @default.
• W2108304057 cites W2183378384 @default.
• W2108304057 cites W2270834115 @default.
• W2108304057 cites W2328340485 @default.
• W2108304057 cites W2335822722 @default.
• W2108304057 cites W2412098032 @default.
• W2108304057 cites W2415140504 @default.
• W2108304057 cites W4205279235 @default.
• W2108304057 cites W56196618 @default.
• W2108304057 doi "https://doi.org/10.1345/aph.1e118" @default.
• W2108304057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15855245" @default.
• W2108304057 hasPublicationYear "2005" @default.
• W2108304057 type Work @default.
• W2108304057 sameAs 2108304057 @default.
• W2108304057 citedByCount "15" @default.
• W2108304057 countsByYear W21083040572012 @default.
• W2108304057 countsByYear W21083040572014 @default.
• W2108304057 countsByYear W21083040572016 @default.
• W2108304057 countsByYear W21083040572018 @default.
• W2108304057 crossrefType "journal-article" @default.
• W2108304057 hasAuthorship W2108304057A5025013886 @default.
• W2108304057 hasAuthorship W2108304057A5030740027 @default.
• W2108304057 hasAuthorship W2108304057A5076594754 @default.
• W2108304057 hasAuthorship W2108304057A5084577356 @default.
• W2108304057 hasConcept C126322002 @default.
• W2108304057 hasConcept C141071460 @default.
• W2108304057 hasConcept C142724271 @default.
• W2108304057 hasConcept C17744445 @default.
• W2108304057 hasConcept C177713679 @default.
• W2108304057 hasConcept C199539241 @default.
• W2108304057 hasConcept C2776301958 @default.
• W2108304057 hasConcept C2777292125 @default.
• W2108304057 hasConcept C2777466982 @default.
• W2108304057 hasConcept C2777987278 @default.
• W2108304057 hasConcept C2778261982 @default.
• W2108304057 hasConcept C2778881276 @default.
• W2108304057 hasConcept C2779161974 @default.
• W2108304057 hasConcept C2779473830 @default.
• W2108304057 hasConcept C2780434524 @default.
• W2108304057 hasConcept C42219234 @default.
• W2108304057 hasConcept C51915194 @default.
• W2108304057 hasConcept C535046627 @default.
• W2108304057 hasConcept C57002609 @default.
• W2108304057 hasConcept C71924100 @default.
• W2108304057 hasConcept C89560881 @default.
• W2108304057 hasConceptScore W2108304057C126322002 @default.
• W2108304057 hasConceptScore W2108304057C141071460 @default.
• W2108304057 hasConceptScore W2108304057C142724271 @default.
• W2108304057 hasConceptScore W2108304057C17744445 @default.
• W2108304057 hasConceptScore W2108304057C177713679 @default.
• W2108304057 hasConceptScore W2108304057C199539241 @default.
• W2108304057 hasConceptScore W2108304057C2776301958 @default.
• W2108304057 hasConceptScore W2108304057C2777292125 @default.
• W2108304057 hasConceptScore W2108304057C2777466982 @default.
• W2108304057 hasConceptScore W2108304057C2777987278 @default.
• W2108304057 hasConceptScore W2108304057C2778261982 @default.
• W2108304057 hasConceptScore W2108304057C2778881276 @default.
• W2108304057 hasConceptScore W2108304057C2779161974 @default.
• W2108304057 hasConceptScore W2108304057C2779473830 @default.
• W2108304057 hasConceptScore W2108304057C2780434524 @default.
• W2108304057 hasConceptScore W2108304057C42219234 @default.
• W2108304057 hasConceptScore W2108304057C51915194 @default.
• W2108304057 hasConceptScore W2108304057C535046627 @default.

• next